# LOUIS STOKES CLEVELAND VA MEDICAL CENTER: TGFβ and Smad Signaling Components in Esophageal Adenocarcinoma

**Lab Budget Score:** 15/100

| Field | Value |
|---|---|
| Organization | LOUIS STOKES CLEVELAND VA MEDICAL CENTER |
| Location | CLEVELAND, OH |
| Project | TGFβ and Smad Signaling Components in Esophageal Adenocarcinoma |
| Project number | 5IK2CX001831-06 |
| Mechanism | IK2 |
| Institute | Veterans Affairs |
| Awarded | 2026-09-18 |
| Project period | 2020-02-01 to 2025-09-30 |
| UEI | KHM6GRQMTKL1 |

## Why this score


Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11249107). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.